Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential newtreatment options to people around the world.
The company is calling for ideas from applicants in Chicago, Detroit, Los Angeles, New Orleans, New York City and Philadelphia with the aim of helping to address racial healthcare disparities at the local level.
Certain gene mutations can dramatically increase the risk of developing aggressive prostate cancer. That's why Johnson & Johnson is researching a new way to fight the disease—one that involves blocking cancer cells from repairing their own damaged DNA.
Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It's for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.
From backing an app that connects Black women to caregivers of color to developing a digital platform that supports surgical recovery, Johnson & Johnson is helping drive the surge of innovation in telemedicine.
Meet Some of the People Working to Create a World of Well